Antifungal agents

Details for Australian Patent Application No. 2008289616 (hide)

Owner Merck Frosst Canada Ltd. Merck Sharp & Dohme Corp. Merck Sharp & Dohme de Espana, SA

Inventors Bills, Gerald F.; Pelaez, Fernando; Parish, Craig A.; Collado, Javier; Platas, Gonzalo; Roemer, Terry

Agent Spruson & Ferguson

Pub. Number AU-A-2008289616

PCT Pub. Number WO2009/025733

Priority 200702289 16.08.07 ES; 60/999,110 16.10.07 US

Filing date 12 August 2008

Wipo publication date 26 February 2009

International Classifications

A01N 43/80 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/42 (2006.01) - Oxazoles

Event Publications

1 July 2010 Section 223 Application Allowed

  Merck Sharp And Dohme De Espana, Sa; Merck Frosst Canada Ltd.; Merck And Co., Inc. The time in which to enter the National Phase has been extended to 16 Apr 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Extensions of Time, Section 223

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/025733 Priority application(s): WO2009/025733

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008289617-Method, apparatus, and system to optimize cardiac preload based on measured pulmonary artery pressure

2008289610-Method and apparatus for synthesizing a copy protection or content control signal with improved playability of a TV set